Clinical Trial Management Systems Market by Product Type, Distribution Channel, End User 2028

1
Global Clinical Trial Management Systems Market
Research and Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Clinical Trial Management Systems Market
Research Report The latest report by IMARC,
titled Clinical Trial Management Systems Market
Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2023-2028 " the global
clinical trial management systems market reached
a value of US 1,033.1 Million in 2022.
Clinical trial management systems (CTMS) refer
to software solutions that are generally used for
managing clinal trials. They are a centralized
web-based enterprise resource system that assists
in medical research studies. Some of the common
features offered by the software include contact
and document management, monitoring, project
planning, contract and payment system, subject
tracking, letter generation and business
analytics. Additionally, they also aid research
professionals in providing easy access to archive
data, thus minimizing the number of delayed
trials. Due to a significant rise in data
generation across the healthcare industry and
research institutions, there has been an
escalating demand for clinical trial management
systems across the globe. Request Free Sample
Report https//www.imarcgroup.com/clinical-trial-
management-systems-market/requestsample
4
Report Description and Highlights
Report Description

Global Clinical Trial Management Systems Market
Trends The global market is primarily driven by
significant growth in biotechnology. Moreover,
increasing investments and funding for conducting
extensive research and development (RD)
activities in medical science are providing a
boost to the market growth. Apart from this,
continual technological advancements and the
widespread integration of cloud computing with
clinical trial management systems are positively
influencing the market growth. Also, numerous
leading companies are heavily investing in the
manufacturing of advanced systems for improving
data quality. Furthermore, the rising utilization
of the software solution for monitoring and
tracking patients information across the globe
is driving the market growth. The rapid
outbreak of coronavirus disease (COVID-19) across
the globe has further propelled the demand for
these systems. Along with this, the rising
prevalence of chronic illnesses and
lifestyle-related disorders among individuals is
also favoring the market growth. Other factors,
including the increasing number of diagnostic
centers and research laboratories and continuous
improvements in the healthcare and pharmaceutical
infrastructure, are further contributing to the
market growth. On account of the aforementioned
factors, the market is anticipated to reach a
value of US 1,953.4 Million by 2028, growing at
a CAGR of 11 during 2023-2028. Looking forward,
the market value is projected to reach a strong
growth during the forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Component Insights Sof
tware Services Deployment Mode Insights
Web-based CTMS On-premise
Cloud-based CTMS End User Insights
Pharmaceutical and Biotechnology Firms
Contract Research Organizations
Others Regional Insights Nor
th America United States
Canada

6
Report Description and Highlights
Report Description
Asia-Pacific China
Japan India
South Korea Austral
ia Indonesia O
thers Europe Germany
France United K
ingdom Italy S
pain Russia Ot
hers Latin America B
razil Mexico
Others Middle East and Africa

7
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Advarra Inc. ArisGlobal LLC BioClinica Inc. DataTr
  ak International Inc. DZS Clinical Services Inc. (
  WDB Holdings Co. Ltd.) International Business Mach
  ines Corporation Medidata Solutions Inc. (Dassault
  Systèmes SE) MedNet Solutions Inc. Oracle Corpora
  tion Parexel International Corporation RealTime So
  ftware Solutions LLC Veeva Systems Inc.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/clinical-trial-manageme
  nt-systems-market

8
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
11

Contact Us